28222-03-9 Usage
Molecular weight
240.64 g/mol This is the mass of one mole of the compound, which is 240.64 grams.
Intermediate in the synthesis of pharmaceuticals and agrochemicals This indicates that the compound is used as a starting material or building block in the production of other chemicals, specifically in the manufacture of drugs and pesticides.
Building block for the production of other organic compounds This suggests that the compound can be used to create other organic molecules, which could have a wide range of applications.
Potential applications in the fields of medicine, agriculture, and materials science This highlights the versatility of the compound and its potential uses in various industries.
Unique chemical structure and properties This emphasizes the distinctiveness of the compound's molecular structure, which may contribute to its potential applications.
Proper safety regulations and guidelines for handling and storage This is a reminder that the compound should be handled and stored with care to ensure the safety of individuals and the environment.
Check Digit Verification of cas no
The CAS Registry Mumber 28222-03-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,2,2 and 2 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 28222-03:
(7*2)+(6*8)+(5*2)+(4*2)+(3*2)+(2*0)+(1*3)=89
89 % 10 = 9
So 28222-03-9 is a valid CAS Registry Number.
28222-03-9Relevant academic research and scientific papers
PYRIDO[2,3-E]OXAZINE DERIVATIVES AS AGRICULTURAL CHEMICALS
-
Page/Page column 42-43, (2021/08/06)
The present invention relates to picolinic acid derivatives that are useful in treating fungal diseases, particularly fungal diseases of agricultural crop plants.
Synthesis and antitumor activities of novel benzoylphenylurea derivatives
Okada,Koyanagi,Yamada,Haga
, p. 2308 - 2315 (2007/10/02)
Seventy novel benzoylphenylurea compounds were synthesized and their antitumor activities were examined in vivo against P388 leukemia. N-(2-Nitrobenzoyl)-N'-[4-(2-pyrimidinyloxy)phenyl]ureas showed the highest antitumor activities when dosed intraperitoneally or orally. Their structure-activity relationships were examined with particular focus on the position and the variety of substituent on each aryl ring.
